Dendritic cell vaccines in the treatment of multiple myeloma: Advances and Limitations
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F65269705%3A_____%2F02%3A00006017" target="_blank" >RIV/65269705:_____/02:00006017 - isvavai.cz</a>
Alternative codes found
RIV/00216224:14110/02:00007783
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Dendritic cell vaccines in the treatment of multiple myeloma: Advances and Limitations
Original language description
Dendritic cells (DCs) are antigen-presenting cells that play a key role in the induction of cytotoxic T-lymphocytes. Adjuvant immunotherapy with antigen-loaded DCs represent an attractive anticancer strategy for multiple myeloma (MM).
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FD - Oncology and haematology
OECD FORD branch
—
Result continuities
Project
<a href="/en/project/GA301%2F00%2F0405" target="_blank" >GA301/00/0405: Translational control of gene expression in mammalian cells transformed by v-src oncogene</a><br>
Continuities
Z - Vyzkumny zamer (s odkazem do CEZ)
Others
Publication year
2002
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Medical Oncology
ISSN
—
e-ISSN
—
Volume of the periodical
2002
Issue of the periodical within the volume
19
Country of publishing house
US - UNITED STATES
Number of pages
6
Pages from-to
213-218
UT code for WoS article
—
EID of the result in the Scopus database
—